Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pieper

Showing results (151-160 of 223) with videos related to

Pageof 23
Sort By:
American Heart Journal|February 28, 2016
Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: Predictors, clinical and angiographic features, and outcomesJohn P Vavalle, Sean van Diepen, Robert M Clare, et al.
The Journal of Invasive Cardiology|September 9, 2004
Temporal spectrum of ischemic complications with percutaneous coronary intervention: the ESPRIT experienceWarren J Cantor, James E Tcheng, James C Blankenship, et al.
The American Journal of Cardiology|October 7, 2004
Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy)Abdallah G Rebeiz, Jean-Pierre Dery, Anastasios A Tsiatis, et al.
The Canadian Journal of Cardiology|August 12, 2009
Effect of operator and institutional volume on clinical outcomes after percutaneous coronary interventions performed in Canada and the United States: a brief report from the Enhanced Suppression of the Platelet glycoprotein IIb/IIIa Receptor with Integrilin Therapy (ESPRIT) studyMina Madan, Janarthan Nikhil, Anne S Hellkamp, et al.
The American Journal of Cardiology|November 15, 2011
Comparison of incidence of bleeding and mortality of men versus women with ST-elevation myocardial infarction treated with fibrinolysisRajendra H Mehta, Amanda S Stebbins, Renato D Lopes, et al.
JAMA|February 10, 2011
Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgeryMichael J Domanski, Kenneth Mahaffey, Vic Hasselblad, et al.
Lancet (London, England)|March 17, 2009
Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II studyRichard C Becker, David J Moliterno, Lisa K Jennings, et al.
Thrombosis and Haemostasis|December 29, 2018
Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE RegistryWalter Ageno, Sylvia Haas, Jeffrey I Weitz, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 17, 2013
Release kinetics of circulating cardiac myosin binding protein-C following cardiac injuryDiederik W D Kuster, Adriana Cardenas-Ospina, Lawson Miller, et al.
Journal of General Internal Medicine|January 16, 2008
Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trialKenneth W Mahaffey, Qinghong Yang, Karen S Pieper, et al.
Pageof 23

Showing results (151-160 of 223) with videos related to

Sort By:
Pageof 23
American Heart Journal|February 28, 2016
Renal failure in patients with ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention: Predictors, clinical and angiographic features, and outcomesJohn P Vavalle, Sean van Diepen, Robert M Clare, et al.
The Journal of Invasive Cardiology|September 9, 2004
Temporal spectrum of ischemic complications with percutaneous coronary intervention: the ESPRIT experienceWarren J Cantor, James E Tcheng, James C Blankenship, et al.
The American Journal of Cardiology|October 7, 2004
Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy)Abdallah G Rebeiz, Jean-Pierre Dery, Anastasios A Tsiatis, et al.
The Canadian Journal of Cardiology|August 12, 2009
Effect of operator and institutional volume on clinical outcomes after percutaneous coronary interventions performed in Canada and the United States: a brief report from the Enhanced Suppression of the Platelet glycoprotein IIb/IIIa Receptor with Integrilin Therapy (ESPRIT) studyMina Madan, Janarthan Nikhil, Anne S Hellkamp, et al.
The American Journal of Cardiology|November 15, 2011
Comparison of incidence of bleeding and mortality of men versus women with ST-elevation myocardial infarction treated with fibrinolysisRajendra H Mehta, Amanda S Stebbins, Renato D Lopes, et al.
JAMA|February 10, 2011
Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgeryMichael J Domanski, Kenneth Mahaffey, Vic Hasselblad, et al.
Lancet (London, England)|March 17, 2009
Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II studyRichard C Becker, David J Moliterno, Lisa K Jennings, et al.
Thrombosis and Haemostasis|December 29, 2018
Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE RegistryWalter Ageno, Sylvia Haas, Jeffrey I Weitz, et al.
American Journal of Physiology. Heart and Circulatory Physiology|December 17, 2013
Release kinetics of circulating cardiac myosin binding protein-C following cardiac injuryDiederik W D Kuster, Adriana Cardenas-Ospina, Lawson Miller, et al.
Journal of General Internal Medicine|January 16, 2008
Prediction of one-year survival in high-risk patients with acute coronary syndromes: results from the SYNERGY trialKenneth W Mahaffey, Qinghong Yang, Karen S Pieper, et al.
Pageof 23